Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

U.S. CDC Says Administered 462.3 Million Doses Of Covid-19 Vaccine As Of Dec 1

12/01/2021 | 05:12pm EST

Dec 1 (Reuters) - U.S. CDC:

* U.S. CDC SAYS ADMINISTERED 462,263,845 DOSES OF COVID-19 VACCINE AS OF DEC 1 VERSUS 460,773,508 DOSES AS OF NOV 30

* U.S. CDC SAYS DELIVERED 575,721,925 DOSES OF COVID-19 VACCINE AS OF DEC 1 VERSUS 573,238,255 DOSES AS OF NOV 30

* U.S. CDC SAYS 233,590,555 INDIVIDUALS HAVE RECEIVED AT LEAST ONE DOSE OF COVID-19 VACCINE AS OF DEC 1 VERSUS 233,207,582 INDIVIDUALS AS OF NOV 30

* U.S. CDC SAYS 197,363,116 INDIVIDUALS HAVE BEEN FULLY VACCINATED AGAINST COVID-19 AS OF DEC 1 VERSUS 197,058,988 INDIVIDUALS AS OF NOV 30

* U.S. CDC SAYS AS OF DECEMBER 1, 41,933,410 PEOPLE RECEIVED A BOOSTER DOSE FOR COVID-19 VACCINE SINCE AUGUST 13, 2021


ę Reuters 2021
All news about MODERNA, INC.
01:29pChile to purchase 2 million Moderna COVID-19 vaccine doses
RE
08:25aLEIDEN UNIVERSITY : mRNA boosters are the most effective upon receiving Janssen vaccinatio..
AQ
06:50aINSIDER SELL : Moderna
MT
05:53aNORTH AMERICAN MORNING BRIEFING : Stocks Seen -3-
DJ
01/21Moderna's Valuation Has Come 'Back to Earth,' Become More Reasonable, BofA Securities S..
MT
01/21Boosters provide 'added protection' against Omicron -CDC
RE
01/21Small children getting less sick from Omicron; Genetic mutation protects against severe..
RE
01/21Booster shots needed against omicron, CDC studies show
AQ
01/21U.S. studies highlight the need for COVID boosters to fight Omicron
RE
01/21CDC : Vaccines less effective against Omicron, but still reduce risk for serious illness
AQ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 644 M - -
Net income 2021 11 173 M - -
Net cash 2021 10 558 M - -
P/E ratio 2021 6,02x
Yield 2021 -
Capitalization 63 777 M 63 777 M -
EV / Sales 2021 3,02x
EV / Sales 2022 1,97x
Nbr of Employees 1 300
Free-Float -
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 160,07 $
Average target price 266,88 $
Spread / Average Target 66,7%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-36.98%64 900
LONZA GROUP AG-15.65%52 307
IQVIA HOLDINGS INC.-14.60%46 031
SEAGEN INC.-17.50%23 323
ICON PUBLIC LIMITED COMPANY-18.65%20 508
CELLTRION, INC.-15.91%19 126